End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,054 INR | -0.23% |
|
+0.77% | +22.37% |
Jul. 09 | Metropolis Healthcare Clocks 13% Increase in Fiscal Q1 Overall Revenue | MT |
May. 22 | Metropolis Healthcare Limited to Seek Acquisitions | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 77.83 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.37% | 1.26B | B+ | ||
-17.44% | 8.58B | B+ | ||
+76.62% | 4.54B | C+ | ||
+14.48% | 2.94B | B- | ||
-3.15% | 2.65B | - | ||
-8.59% | 1.89B | C- | ||
-53.65% | 1.86B | B- | ||
-13.64% | 1.56B | A- | ||
-46.33% | 1.09B | C+ | ||
+16.04% | 963M | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- METROPOLIS Stock
- Ratings Metropolis Healthcare Limited